Scientists share detailed, complete images of a viral structure called the Ebola virus nucleocapsid. This breakthrough may accelerate the development of antivirals that target this viral structure to ...
Ebola virus disease kills more than half of people infected. Since the disease is transmitted via close human contact, ...
At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The only approved vaccine and antibody treatments protect against just one filovirus species.
Not only that, but there are very few tools (vaccines or drugs) to combat them ... In a new study, the researchers used ...
Researchers have detailed the structure of the Ebola virus nucleocapsid using cryo-electron tomography. This discovery could ...
Nigeria: Ten Years After Ebola - Learnings for Lassa Fever, 'Lassa-X' and Pandemic Preparedness Lead
Blog - In global health, past epidemics are important learning experiences that shape our responses to future health emergencies. The 2014 Ebola epidemic in West Africa serves as a stark reminder of ...
Vaccine effectiveness was estimated using odds ratio calculations, which determined that 10 days after vaccination, rVSV-ZEBOV was 80 per cent effective against the Ebola virus in females ...
LA JOLLA, CA-At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The ...
Researchers from Thomas Jefferson University and the University of Maryland Baltimore, in collaboration with the United ...
A promising Lassa fever vaccine shows potential to prevent severe disease and death in animals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback